A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.

Inflammation contributes to knee osteoarthritis (KOA) where many immunological mediators participate in its initiation and progression. Most clinicians manage primary (pKOA) and secondary osteoarthritis (sKOA) alike. Whether immunological profiles of pKOA and sKOA differ remains obscure. Hence, we a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sakuni Rankothgedera, Inoshi Atukorala, Chandrika Fernando, Duminda Munidasa, Lalith Wijayaratne, Preethi Udagama
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/26a73833bdde4e1a9cfaa4ac292b05af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:26a73833bdde4e1a9cfaa4ac292b05af
record_format dspace
spelling oai:doaj.org-article:26a73833bdde4e1a9cfaa4ac292b05af2021-12-02T20:14:27ZA potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.1932-620310.1371/journal.pone.0257507https://doaj.org/article/26a73833bdde4e1a9cfaa4ac292b05af2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257507https://doaj.org/toc/1932-6203Inflammation contributes to knee osteoarthritis (KOA) where many immunological mediators participate in its initiation and progression. Most clinicians manage primary (pKOA) and secondary osteoarthritis (sKOA) alike. Whether immunological profiles of pKOA and sKOA differ remains obscure. Hence, we aimed to differentially identify potential serum immunologic diagnostic markers of pKOA and of sKOA. This case control study used 46 KOA patients (pKOA, n = 30; sKOA, n = 16), and 60 age, gender matched controls (normal healthy, n = 30; systemic lupus erythematosus [SLE] disease controls, n = 30) where serum was assayed for cytokines (TNF-α, IL-1β, IL-6, IL-10) and nitric oxide derivatives (NOx). Sandwich ELISA assessed cytokine levels, while the 'Griess assay' quantified NOx levels. The diagnostic accuracy of optimal marker combinations was evaluated by the CombiROC web tool. Compared with pKOA, sKOA serum displayed significantly elevated levels of pro inflammatory cytokines (TNF-α, IL-1β, IL-6) with a concurrent decrease in the anti-inflammatory cytokine, IL-10 (P<0.05). This was reiterated by significantly higher Th1:Th2 (TNF-α: IL-10) serum cytokine ratio observed in sKOA compared to that of pKOA. The CombiROC curves identified TNF-α, IL-1β, IL-6 and NOx as the best performing panel of potential diagnostic markers to discriminate pKOA from control groups (~97% accuracy, 90% Sensitivity [SE] and 98% specificity [SP]), while TNF-α, IL-1β and IL-6 discriminated sKOA from control groups (~100% accuracy, 100% SE, and 98% SP). The study identified discrete serum immune biomarker panels to differentiate between pKOA (TNF-α, IL-1β, IL-6 and NOx) and sKOA (TNF-α, IL-1β and IL-6). These findings may assist in developing distinct therapeutic agents for the two types of KOA.Sakuni RankothgederaInoshi AtukoralaChandrika FernandoDuminda MunidasaLalith WijayaratnePreethi UdagamaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257507 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sakuni Rankothgedera
Inoshi Atukorala
Chandrika Fernando
Duminda Munidasa
Lalith Wijayaratne
Preethi Udagama
A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
description Inflammation contributes to knee osteoarthritis (KOA) where many immunological mediators participate in its initiation and progression. Most clinicians manage primary (pKOA) and secondary osteoarthritis (sKOA) alike. Whether immunological profiles of pKOA and sKOA differ remains obscure. Hence, we aimed to differentially identify potential serum immunologic diagnostic markers of pKOA and of sKOA. This case control study used 46 KOA patients (pKOA, n = 30; sKOA, n = 16), and 60 age, gender matched controls (normal healthy, n = 30; systemic lupus erythematosus [SLE] disease controls, n = 30) where serum was assayed for cytokines (TNF-α, IL-1β, IL-6, IL-10) and nitric oxide derivatives (NOx). Sandwich ELISA assessed cytokine levels, while the 'Griess assay' quantified NOx levels. The diagnostic accuracy of optimal marker combinations was evaluated by the CombiROC web tool. Compared with pKOA, sKOA serum displayed significantly elevated levels of pro inflammatory cytokines (TNF-α, IL-1β, IL-6) with a concurrent decrease in the anti-inflammatory cytokine, IL-10 (P<0.05). This was reiterated by significantly higher Th1:Th2 (TNF-α: IL-10) serum cytokine ratio observed in sKOA compared to that of pKOA. The CombiROC curves identified TNF-α, IL-1β, IL-6 and NOx as the best performing panel of potential diagnostic markers to discriminate pKOA from control groups (~97% accuracy, 90% Sensitivity [SE] and 98% specificity [SP]), while TNF-α, IL-1β and IL-6 discriminated sKOA from control groups (~100% accuracy, 100% SE, and 98% SP). The study identified discrete serum immune biomarker panels to differentiate between pKOA (TNF-α, IL-1β, IL-6 and NOx) and sKOA (TNF-α, IL-1β and IL-6). These findings may assist in developing distinct therapeutic agents for the two types of KOA.
format article
author Sakuni Rankothgedera
Inoshi Atukorala
Chandrika Fernando
Duminda Munidasa
Lalith Wijayaratne
Preethi Udagama
author_facet Sakuni Rankothgedera
Inoshi Atukorala
Chandrika Fernando
Duminda Munidasa
Lalith Wijayaratne
Preethi Udagama
author_sort Sakuni Rankothgedera
title A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
title_short A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
title_full A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
title_fullStr A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
title_full_unstemmed A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
title_sort potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/26a73833bdde4e1a9cfaa4ac292b05af
work_keys_str_mv AT sakunirankothgedera apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT inoshiatukorala apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT chandrikafernando apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT dumindamunidasa apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT lalithwijayaratne apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT preethiudagama apotentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT sakunirankothgedera potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT inoshiatukorala potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT chandrikafernando potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT dumindamunidasa potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT lalithwijayaratne potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
AT preethiudagama potentialdiagnosticserumimmunologicalmarkerpaneltodifferentiatebetweenprimaryandsecondarykneeosteoarthritis
_version_ 1718374633592324096